DETROIT - Recently, a tiny group of people with rectal cancer saw their disease vanish after experimental treatment. It was a very small trial done by doctors at New York's Memorial Sloan Kettering Cancer Center, wherein the patients took a drug called dostarlimab for six months. At the end of their trial, every single one of their
NEW YORK - In what appears to be a very promising breakthrough for the treatment of rectal cancer, a small drug trial conducted in the US found every patient treated in the experiment had their cancer successfully go into remission. The medication given, called dostarlimab and sold under the brand name Jemperli, is an immunotherapy drug used
GRAND RAPIDS - Grand Valley State University received $1 million in federal appropriations to expand its applied Medical Device Institute (aMDI) and provide new technologies that will better serve the medical innovation industry while expanding West Michigan's economic footprint. U.S. Rep. Peter Meijer, (R-Mich.), requested and received this funding, which was packaged into the 2022
SOUTHFIELD - Spectrum Health and Beaumont Health announced Jan. 31 that they plan to close their merger on Tuesday after federal trade regulators signed off on the deal. The new mega healthcare system will be temporarily known as BHSH System. “We are grateful for all of our physicians, nurses and team members. Their compassion, expertise
KALAMAZOO - Stryker announced on Thursday a definitive merger agreement to acquire Vocera Communications for $3.09 billion. Vocera provides a platform for digital care coordination and communication strategy, offering a portfolio that is complementary to Stryker’s division that focuses on technologies that address connecting hospitals with caregivers, and data-generating medical devices. “Vocera’s highly developed software
ANN ARBOR - Scientists have identified how a protein in the brain uses information about the body’s energy balance to regulate growth rate and the onset of puberty in children. The research, published Nov. 3 in the journal Nature(link is external), centered on the melanocortin 3 receptor (MC3R), a member of a family of proteins that
KALAMAZOO—C2Dx Inc., a medical device company, announced a partnership with another Michigan startup, Farmington Hills-based Quintree. Quintree claims to be the first telemedicine platform that integrates with existing diagnostic equipment. It was created by Dr. Adam Folbe, a practicing ear, nose, and throat doctor, and Sandy Kronenberg, an IT expert and entrepreneur, with the mission to drive higher efficiencies
BRIGHTON - The Michigan Health Endowment Fund named Neel Hajra its next chief executive officer. Hajra comes to the Health Fund after serving since 2015 as CEO of the Ann Arbor Area Community Foundation. “We are thrilled to have Neel Hajra join the Health Fund to help advance our mission to improve the health and
ANN ARBOR—BlueWillow Biologics Inc., a privately held clinical-stage biopharmaceutical company developing intranasal vaccines, announced positive interim results from the Phase 1 clinical trial of BW-1010, its next-generation intranasal anthrax vaccine candidate. BW-1010 combines BlueWillow’s patented technology, a novel oil-in-water emulsion platform that efficiently presents antigens to the immune system via the nasal mucosa, using recombinant protective
BRIGHTON – Medical device maker FlexDex announced Monday it has completed a $13 million Series AA funding round for next generation advanced laparoscopic devices. The financing will be used to fund development of the Company’s next generation articulating needle driver for endoscopic suturing and a full suite of advanced laparoscopic instruments with robotic functionality. The
